Astec LifeSciences share news, announcements and annual reports
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Astec LifeSciences Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2009
Last close ₹581.05down ₹21.90 (3.63%)BSE ₹581.30
Share price at the NSE close on 29 Oct 2026. Previous close ₹602.95.
29 Oct: open ₹598.00, high ₹606.95, low ₹569.45
52-week range of traded prices to 29 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,295 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.87
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −7.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 74,47843.9% delivered
Astec LifeSciences disputes and clarifications
29 filed, newest first.
Oct 2026
1 Oct · Legal
The exchange asked on 30 Sep 2026
Sep 2026
18 Sep · Legal
The exchange asked on 17 Sep 2026
11 Sep · Legal
The exchange asked on 10 Sep 2026
9 Sep · Legal
The exchange asked on 8 Sep 2026
Jun 2026
1 Jun · Legal
The exchange asked on 29 May 2026
Apr 2026
20 Apr · Legal
The exchange asked on 17 Apr 2026
Feb 2026
6 Feb · Legal
The exchange asked on 5 Feb 2026
Aug 2025
1 Aug · Legal
Mar 2025
5 Mar · Legal
Exchange has sought clarification from Astec LifeSciences Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Jan 2025
6 Jan · Legal
The exchange asked on 3 Jan 2025
Mar 2024
6 Mar · Legal
The exchange asked on 5 Mar 2024
Aug 2023
10 Aug · Legal
The exchange asked on 9 Aug 2023
Jun 2023
8 Jun · Legal
The exchange asked on 7 Jun 2023
Mar 2023
30 Mar · Legal
The exchange asked on 29 Mar 2023
Oct 2022
14 Oct · Legal
The exchange asked on 13 Oct 2022
May 2022
3 May · Legal
The exchange asked on 2 May 2022
Dec 2021
14 Dec · Legal
The exchange asked on 13 Dec 2021
Aug 2021
Jul 2021
30 Jul · Legal
Exchange has sought clarification from Astec LifeSciences Limited with respect to announcement dated 27-Jul-2021, regarding Disruption of operations. On basis of above the Company is required to clarify following:1. Expected quantum of loss/damage caused; 2. Whether loss/damage covered by insurance or not including amount; The response of the Company is awaited.
May 2021
25 May · Legal
The exchange asked on 24 May 2021
Jun 2020
26 Jun · Legal
The exchange asked on 24 Jun 2020
Jul 2017
21 Jul · Legal
The exchange asked on 20 Jul 2017
Oct 2016
10 Oct · Legal
The exchange asked on 7 Oct 2016
Aug 2016
22 Aug · Legal
Significant increase in volume has been observed in Astec LifeSciences Limited . The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Jul 2016
27 Jul · Legal
Exchange has sought clarification from the Company with respect to announcement dated July 26, 2016, regarding the Outcome of Board Meeting of the Company held on July 26, 2016.On basis of above the Company is required to clarify following:1. Reason for change viz. appointment, 2. Brief profile (in case of appointment).The response of the Company is awaited.
Jun 2016